An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike | Nature
Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants - Ong - 2023 - Journal of Medical Virology - Wiley Online Library
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization - ScienceDirect
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
SARS‐CoV‐2 variants and spike mutations involved in second wave of COVID‐19 pandemic in India - Muttineni - 2022 - Transboundary and Emerging Diseases - Wiley Online Library
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination - ScienceDirect
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity | Science Advances
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Guidance for surveillance of SARS-CoV-2 variants
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant | The Journal of Physical Chemistry Letters
Fast Prediction of Binding Affinities of SARS-CoV-2 Spike Protein and Its Mutants with Antibodies through Intermolecular Interaction Modeling-Based Machine Learning | The Journal of Physical Chemistry B
Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam | BMC Infectious Diseases | Full Text
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants - ScienceDirect
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant | Clinical Microbiology Reviews
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses | Science Immunology
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Science Translational Medicine
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Science Translational Medicine
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies - ScienceDirect
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? - The Lancet Respiratory Medicine
